Authors:
Tahtis, K
Lee, FT
Smyth, FE
Power, BE
Renner, C
Brechbiel, MW
Old, LJ
Hudson, PJ
Scott, AM
Citation: K. Tahtis et al., Biodistribution properties of (111)Indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab ')(2) constructs in a breast carcinoma xenograft model, CLIN CANC R, 7(4), 2001, pp. 1061-1072
Authors:
Scott, AM
Lee, FT
Hopkins, W
Cebon, JS
Wheatley, JM
Liu, ZQ
Smyth, FE
Murone, C
Sturrock, S
MacGregor, D
Hanai, N
Inoue, K
Yamasaki, M
Brechbiel, MW
Davis, ID
Murphy, R
Hannah, A
Lim-Joon, M
Chan, T
Chong, G
Ritter, G
Hoffman, EW
Burgess, AW
Old, LJ
Citation: Am. Scott et al., Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: Results of a phase I trial, J CL ONCOL, 19(19), 2001, pp. 3976-3987
Authors:
Power, BE
Caine, JM
Burns, JE
Shapira, DR
Hattarki, MK
Tahtis, K
Lee, FT
Smyth, FE
Scott, AM
Kortt, AA
Hudson, PJ
Citation: Be. Power et al., Construction, expression and characterisation of a single-chain diabody derived from a humanised anti-Lewis Y cancer targeting antibody using a heat-inducible bacterial secretion vector, CANCER IMMU, 50(5), 2001, pp. 241-250
Authors:
Lee, FT
Hall, C
Rigopoulos, A
Zweit, J
Pathmaraj, K
O'Keefe, GJ
Smyth, FE
Welt, S
Old, LJ
Scott, AM
Citation: Ft. Lee et al., Immune-PET of human colon xenograft-bearing BALB/c nude mice using I-124-CDR-grafted humanized A33 monoclonal antibody, J NUCL MED, 42(5), 2001, pp. 764-769
Authors:
Lee, FT
Rigopoulos, A
Hall, C
Clarke, K
Cody, SH
Smyth, FE
Liu, ZQ
Brechbiel, MW
Hanai, N
Nice, EC
Catimel, B
Burgess, AW
Welt, S
Ritter, G
Old, LJ
Scott, AM
Citation: Ft. Lee et al., Specific localization, gamma camera imaging, and intracellular traffickingof radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871in SK-MEL-28 melanoma xenografts, CANCER RES, 61(11), 2001, pp. 4474-4482
Authors:
Clarke, K
Lee, FT
Brechbiel, MW
Smyth, FE
Old, LJ
Scott, AM
Citation: K. Clarke et al., Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: Enhanced activity when combined with taxol chemotherapy, CLIN CANC R, 6(9), 2000, pp. 3621-3628
Authors:
Clarke, K
Lee, FT
Brechbiel, MW
Smyth, FE
Old, LJ
Scott, AM
Citation: K. Clarke et al., In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice, CANCER RES, 60(17), 2000, pp. 4804-4811
Authors:
Scott, AM
Geleick, D
Rubira, M
Clarke, K
Nice, EC
Smyth, FE
Stockert, E
Richards, EC
Carr, FJ
Harris, WJ
Armour, KL
Rood, J
Kypridis, A
Kronina, V
Murphy, R
Lee, FT
Liu, ZQ
Kitamura, K
Ritter, G
Laughton, K
Hoffman, E
Burgess, AW
Old, LJ
Citation: Am. Scott et al., Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors, CANCER RES, 60(12), 2000, pp. 3254-3261